Variant report

Variant	esv33610
Chromosome Location	chr7:100324874-100337084
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:45)
CpG islands
(count:183)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:45 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr7:100325083-100325234	HepG2	liver:	n/a	n/a
2	CEBPB	chr7:100328148-100328292	A549	lung:	n/a	chr7:100328193-100328204
3	CEBPB	chr7:100328099-100328290	IMR90	lung:	n/a	chr7:100328193-100328204
4	CEBPB	chr7:100324990-100325273	HepG2	liver:	n/a	n/a
5	CEBPB	chr7:100328040-100328372	HepG2	liver:	n/a	chr7:100328193-100328204
6	CEBPB	chr7:100328044-100328375	HepG2	liver:	n/a	chr7:100328193-100328204
7	CEBPB	chr7:100328137-100328308	Hela-S3	cervix:	n/a	chr7:100328193-100328204
8	CEBPB	chr7:100328048-100328277	K562	blood:	n/a	chr7:100328193-100328204
9	CEBPD	chr7:100328091-100328340	HepG2	liver:	n/a	n/a
10	CTCF	chr7:100334240-100334390	HepG2	liver:	n/a	n/a
11	CTCF	chr7:100329480-100329513	GM13976	blood:	n/a	n/a
12	EP300	chr7:100324911-100325036	HepG2	liver:	n/a	n/a
13	FAM48A	chr7:100328354-100328449	GM12878	blood:	n/a	n/a
14	FOSL2	chr7:100324947-100325311	HepG2	liver:	n/a	n/a
15	FOXA1	chr7:100324901-100325371	HepG2	liver:	n/a	n/a
16	FOXA1	chr7:100336911-100337230	HepG2	liver:	n/a	n/a
17	FOXA1	chr7:100324969-100325336	HepG2	liver:	n/a	n/a
18	FOXA1	chr7:100324912-100325424	HepG2	liver:	n/a	n/a
19	FOXA1	chr7:100324869-100325321	HepG2	liver:	n/a	n/a
20	FOXA1	chr7:100325130-100325284	T-47D	breast:	n/a	n/a
21	FOXA2	chr7:100324965-100325301	HepG2	liver:	n/a	n/a
22	FOXA2	chr7:100324913-100325419	A549	lung:	n/a	n/a
23	FOXA2	chr7:100336974-100337182	HepG2	liver:	n/a	n/a
24	HNF4A	chr7:100334443-100334631	HepG2	liver:	n/a	n/a
25	MAX	chr7:100324882-100325456	HepG2	liver:	n/a	n/a
26	MAX	chr7:100325186-100325218	HepG2	liver:	n/a	n/a
27	MXI1	chr7:100325108-100325268	HepG2	liver:	n/a	n/a
28	PAX5	chr7:100325889-100326136	GM12878	blood:	n/a	chr7:100326022-100326040
29	PAX5	chr7:100325862-100326185	GM12878	blood:	n/a	chr7:100326022-100326040
30	PAX5	chr7:100329892-100330334	GM12891	blood:	n/a	n/a
31	POLR2A	chr7:100331776-100331843	K562	blood:	n/a	n/a
32	POLR2A	chr7:100334514-100334693	HepG2	liver:	n/a	n/a
33	POLR2A	chr7:100334504-100334656	HepG2	liver:	n/a	n/a
34	POLR2A	chr7:100329481-100329606	H1-hESC	embryonic stem cell:	n/a	n/a
35	POLR2A	chr7:100329493-100329614	H1-hESC	embryonic stem cell:	n/a	n/a
36	POLR2A	chr7:100320924-100325973	K562	blood:	n/a	n/a
37	POLR2A	chr7:100334700-100334719	HepG2	liver:	n/a	n/a
38	POLR2A	chr7:100335245-100335321	GM12878	blood:	n/a	n/a
39	RCOR1	chr7:100325171-100325342	HepG2	liver:	n/a	n/a
40	SP1	chr7:100329335-100329646	HepG2	liver:	n/a	n/a
41	STAT1	chr7:100324970-100325437	Hela-S3	cervix:	n/a	n/a
42	USF1	chr7:100325053-100325293	HepG2	liver:	n/a	chr7:100325200-100325211
43	USF1	chr7:100325032-100325307	HepG2	liver:	n/a	chr7:100325200-100325211
44	ZBTB7A	chr7:100328037-100328215	HepG2	liver:	n/a	n/a
45	ZNF384	chr7:100330766-100330914	K562	blood:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:100330872-100330922	NHDF-neo	bronchial:	n/a
2	chr7:100330109-100330159	NT2-D1	testis:	n/a
3	chr7:100330587-100330637	HCM	heart:	n/a
4	chr7:100330109-100330159	NB4	blood:	n/a
5	chr7:100330109-100330159	MCF10A-Er-Src	breast:	n/a
6	chr7:100330872-100330922	SAEC	small airway:	n/a
7	chr7:100330587-100330637	AG09309	skin:	n/a
8	chr7:100330587-100330637	HUVEC	blood vessel:	n/a
9	chr7:100330587-100330637	Jurkat	blood:	n/a
10	chr7:100330109-100330159	K562	blood:	n/a
11	chr7:100330109-100330159	BJ	skin:	n/a
12	chr7:100330872-100330922	SKMC	muscle:	n/a
13	chr7:100330872-100330922	HEK293	kidney:	embryo
14	chr7:100330109-100330159	SAEC	small airway:	n/a
15	chr7:100330109-100330159	MCF-7	breast:	n/a
16	chr7:100330587-100330637	GM06990	blood:	n/a
17	chr7:100330587-100330637	HCF	heart:	n/a
18	chr7:100330872-100330922	HRCEpiC	kidney:	n/a
19	chr7:100330109-100330159	A549	lung:	n/a
20	chr7:100330872-100330922	GM06990	blood:	n/a
21	chr7:100330872-100330922	AG10803	skin:	n/a
22	chr7:100330109-100330159	HepG2	liver:	n/a
23	chr7:100330109-100330159	HEEpiC	esophagus:	n/a
24	chr7:100330109-100330159	SK-N-MC	brain:	n/a
25	chr7:100330872-100330922	AG04449	skin:	fetal
26	chr7:100330872-100330922	ECC-1	luminal epithelium:	n/a
27	chr7:100330587-100330637	ovcar-3	ovarian:	n/a
28	chr7:100330872-100330922	AG09319	gingival:	n/a
29	chr7:100330109-100330159	BE2_C	brain:	n/a
30	chr7:100330587-100330637	BE2_C	brain:	n/a
31	chr7:100330872-100330922	AG04450	lung:	fetal
32	chr7:100330109-100330159	Jurkat	blood:	n/a
33	chr7:100330587-100330637	BJ	skin:	n/a
34	chr7:100330109-100330159	ECC-1	luminal epithelium:	n/a
35	chr7:100330872-100330922	HEEpiC	esophagus:	n/a
36	chr7:100330109-100330159	Caco-2	colon:	n/a
37	chr7:100330872-100330922	ProgFib	skin:	n/a
38	chr7:100330587-100330637	PrEC	prostate:	n/a
39	chr7:100330872-100330922	HIPEpiC	eye:	n/a
40	chr7:100330109-100330159	AG09309	skin:	n/a
41	chr7:100330872-100330922	BE2_C	brain:	n/a
42	chr7:100330109-100330159	AG10803	skin:	n/a
43	chr7:100330109-100330159	HNPCEpiC	eye:	n/a
44	chr7:100330587-100330637	HPAEpiC	pulmonary alveolar:	n/a
45	chr7:100330872-100330922	HCPEpiC	choroid plexus:	n/a
46	chr7:100330872-100330922	K562	blood:	n/a
47	chr7:100330872-100330922	SK-N-SH	brain:	n/a
48	chr7:100330109-100330159	HCM	heart:	n/a
49	chr7:100330872-100330922	HNPCEpiC	eye:	n/a
50	chr7:100330587-100330637	SK-N-MC	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:100336156..100338514-chr7:100343827..100346025,2	K562	blood:
2	chr7:100324153..100326301-chr7:100361628..100364421,2	K562	blood:
3	chr7:100181969..100184766-chr7:100322000..100326304,4	MCF-7	breast:
4	chr7:100322778..100325308-chr7:100423819..100426319,3	MCF-7	breast:
5	chr7:100303316..100305278-chr7:100323603..100325231,2	K562	blood:
6	chr7:100326112..100327796-chr7:100392464..100395372,2	MCF-7	breast:
7	chr7:100321531..100325332-chr7:100423998..100426364,3	MCF-7	breast:
8	chr7:100325203..100328007-chr7:100356386..100357913,2	K562	blood:
9	chr7:100317007..100319008-chr7:100325168..100326733,2	K562	blood:

No data

Variant related genes	Relation type
ZAN	TF binding region
ZAN	CpG island
ENSG00000196411	chromatin interactions
ENSG00000077454	chromatin interactions
ENSG00000172336	chromatin interactions
ENSG00000130427	chromatin interactions
ENSG00000106336	chromatin interactions
ENSG00000146828	chromatin interactions

Extended variants
information (count: 473 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:473 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs568499254	chr7:100324886-100324887	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs549577686	chr7:100324898-100324899	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs566061829	chr7:100324965-100324966	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs143012945	chr7:100324970-100324971	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs554878382	chr7:100325015-100325016	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs576409577	chr7:100325094-100325095	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs543565598	chr7:100325123-100325124	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs558512142	chr7:100325139-100325140	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs147524860	chr7:100325144-100325145	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs540797085	chr7:100325145-100325146	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs558909617	chr7:100325230-100325231	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs529613025	chr7:100325339-100325340	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs192748596	chr7:100325421-100325422	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs563599020	chr7:100325438-100325439	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs531149295	chr7:100325472-100325473	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs555207991	chr7:100325476-100325477	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs552732149	chr7:100325531-100325532	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs561475770	chr7:100325612-100325613	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs564769917	chr7:100325627-100325628	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs79641961	chr7:100325628-100325629	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs398067117	chr7:100325637-100325638	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs528568139	chr7:100325653-100325654	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs565636878	chr7:100325731-100325732	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs73409077	chr7:100325755-100325756	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs183859742	chr7:100325783-100325784	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs187420936	chr7:100325795-100325796	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs557403791	chr7:100325900-100325901	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs569960027	chr7:100325905-100325906	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs536992203	chr7:100325910-100325911	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs199654561	chr7:100325937-100325938	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs368725299	chr7:100325938-100325939	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs371068549	chr7:100325939-100325940	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs558696274	chr7:100325962-100325963	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs191902855	chr7:100325967-100325968	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs34603811	chr7:100326000-100326001	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs144139501	chr7:100326001-100326002	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs551665823	chr7:100326074-100326075	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs111424437	chr7:100326157-100326158	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs551131073	chr7:100326161-100326162	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs184328851	chr7:100326164-100326165	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs562988521	chr7:100326165-100326166	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs531213259	chr7:100326222-100326223	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs374962131	chr7:100326238-100326239	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs546213353	chr7:100326267-100326268	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs116584510	chr7:100326273-100326274	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs74299683	chr7:100326315-100326316	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs56394908	chr7:100326356-100326357	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs547220058	chr7:100326370-100326371	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs568527160	chr7:100326371-100326372	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs529448777	chr7:100326372-100326373	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:68 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100319200-100342800	Weak transcription	Right Atrium	heart
2	chr7:100322000-100326400	Enhancers	HepG2	liver
3	chr7:100322200-100325400	Enhancers	Liver	Liver
4	chr7:100322800-100325400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr7:100323400-100325400	Bivalent Enhancer	Fetal Muscle Leg	muscle
6	chr7:100323400-100325400	Bivalent Enhancer	Fetal Stomach	stomach
7	chr7:100323600-100325600	Enhancers	HSMM	muscle
8	chr7:100323800-100325000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr7:100323800-100325200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr7:100323800-100325400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr7:100323800-100325400	Enhancers	NH-A	brain
12	chr7:100323800-100326400	Enhancers	HSMMtube	muscle
13	chr7:100323800-100328000	Weak transcription	Hela-S3	cervix
14	chr7:100323800-100334400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr7:100324000-100325000	Enhancers	Fetal Muscle Trunk	muscle
16	chr7:100324000-100325400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr7:100324000-100325400	Enhancers	Osteobl	bone
18	chr7:100324000-100325800	Enhancers	Muscle Satellite Cultured Cells	--
19	chr7:100324200-100325600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr7:100324200-100325600	Enhancers	NHLF	lung
21	chr7:100324200-100326000	Enhancers	NHDF-Ad	bronchial
22	chr7:100324400-100325000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr7:100324600-100325200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
24	chr7:100324600-100325200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr7:100324600-100325200	Enhancers	A549	lung
26	chr7:100324800-100325200	Enhancers	ES-I3 Cell Line	embryonic stem cell
27	chr7:100324800-100325200	Enhancers	Duodenum Smooth Muscle	Duodenum
28	chr7:100324800-100325400	Weak transcription	Placenta Amnion	Placenta Amnion
29	chr7:100324800-100325800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr7:100325000-100325200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr7:100325200-100325400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr7:100325200-100325400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr7:100325200-100325600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
34	chr7:100325200-100326200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr7:100325400-100325600	Enhancers	Placenta Amnion	Placenta Amnion
36	chr7:100325400-100333000	Weak transcription	Liver	Liver
37	chr7:100325800-100326000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr7:100326000-100326200	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
39	chr7:100326400-100327800	Weak transcription	HepG2	liver
40	chr7:100327800-100328000	Enhancers	HepG2	liver
41	chr7:100327800-100328000	Bivalent Enhancer	HSMMtube	muscle
42	chr7:100328000-100328200	Enhancers	Hela-S3	cervix
43	chr7:100328000-100328200	Flanking Active TSS	HepG2	liver
44	chr7:100328200-100328400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr7:100328200-100328400	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr7:100328200-100328800	Enhancers	HepG2	liver
47	chr7:100328400-100328600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr7:100328800-100329200	Weak transcription	HepG2	liver
49	chr7:100329200-100334400	Enhancers	HepG2	liver
50	chr7:100329600-100331000	Enhancers	Primary B cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links